Full name
APOLLO-MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
49.42.Z - Moving services
66.22.Z - Insurance agent and broker activities
66.29.Z - Activities supporting insurance and pension funds, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,3 | -0 | -0,1 | -449,1 |
EBITDA | 0,3 | 0 | -0,1 | -616,8 |
Short time liabilities | 0,5 | 1 | 1 | 1,3 |
Equity capital | 1,4 | 1,3 | 1,2 | -8,1 |
Operating profit (EBIT) | 0,3 | 0 | -0,1 | -1555,3 |
Assets | 2 | 2,5 | 2,3 | -7 |
Net profit (loss) | 0,3 | -0 | -0,1 | -172,8 |
Cash | 1,2 | 1,6 | 1,6 | -1,7 |
Net income from sale | 6,3 | 4,6 | 5,3 | 14,3 |
Liabilities and provisions for liabilities | 0,6 | 1,2 | 1,1 | -5,7 |
Working assets | 1,9 | 2,4 | 2,2 | -7 |
Depreciation | 0 | 0 | 0 | -34 |
% | % | % | p.p. | |
Profitability of capital | 19,8 | -3 | -8,8 | -5,8 |
Equity capital to total assets | 68,9 | 53,4 | 52,7 | -0,7 |
Gross profit margin | 4,6 | -0,4 | -2,1 | -1,7 |
EBITDA Margin | 5,1 | 0,3 | -1,5 | -1,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 31 | 78 | 69 | -9 |
Current financial liquidity indicator | 3.461017370223999 | 2.39597487449646 | 2.2193315029144287 | -0,2 |
Net dept to EBITDA | -3.632218360900879 | -89.36319732666016 | 17.827421188354492 | 107,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane